Results 241 to 250 of about 1,617,912 (396)

Catheter removal and outcomes of multidrug-resistant central-line-associated bloodstream infection [PDF]

, 2018
Burnham, Jason P., Kollef, Marin H., Rojek, Rebecca P.   +2 more
core   +1 more source

Unilateral Acroangiodermatitis: From Histopathologic Confirmation to Treatment with PDL. [PDF]

Dermatopathology (Basel)
Aparício Martins A, Cardoso JC, Pinho A.   +2 more
europepmc   +1 more source

Sabotaged Integral HSC Heterogeneity Underlies Essential Thrombocythemia Development

Advanced Science, EarlyView.
Single‐cell RNA sequencing (scRNA‐seq) maps how distinct driver mutations remodel hematopoietic stem cell (HSC) programs across essential thrombocythemia (ET). Comparative analysis uncovers both shared and subtype‐specific molecular signatures, identifies a triple‐negative (TN)‐associated HSC population enriched with malignant traits, and reveals the ...
Jingyuan Tong, Di Wang, Haoze Song, Ting Sun, Yanhong Zhao, Wenjing Gu, Lexuan Lin, Yitong Zhao, Yipeng Liang, Xu Jin, Rongfeng Fu, Mankai Ju, Jie Gao, Jinfa Ma, Chengjie Gao, Anqi Zhang, Zhijian Xiao, Erlie Jiang, Renchi Yang, Shihui Ma, Lei Zhang, Lihong Shi   +21 more
wiley   +1 more source

Pathophysiological mechanisms of chronic venous disease and their role in C0s clinical class

, 2018
Andrew Nicolaides, Eliete Bouskela
openalex   +1 more source

Impact of hemodynamic doppler ultrasound parameters on patency and post-thrombotic syndrome in patients with iliofemoral venous stents. [PDF]

Sci Rep
Skaff Y, Douane F, Chastaingt L, Morard M, Maurel B, Kallassy C, Espinasse B, Dari L, Espitia O.   +8 more
europepmc   +1 more source

CircSMEK1 Suppresses HCC via the hnRNPK‐IGF2‐AKT Axis: A Diagnostic Biomarker and Therapeutic Target

Advanced Science, EarlyView.
CircSMEK1 is downregulated in MASH/HCC and predicts poor prognosis. It suppresses tumor progression by promoting hnRNPK ubiquitination and inhibiting the IGF2/PI3K/AKT axis, while its loss activates immunosuppressive cancer‐associated fibroblasts. Serum circSMEK1 serves as a non‐invasive diagnostic biomarker, and its restoration potently inhibits HCC ...
Peilan Guo, Xiaomeng Jia, Shenghong Wang, Xinyu Li, Yajing Liu, Lisen Lin, Zhengkun Wang, Fujun Liu, Slawomir Wolczynski, Nafis Rahman, Jie Gao, Xuguang Du, Suk‐Ying Tsang, Jiali Liu, Wei Song, Xiangdong Li   +15 more
wiley   +1 more source

The burden of chronic venous diseases is unknown [PDF]

Phlebology: The Journal of Venous Disease, 2010
openaire   +2 more sources

Therapeutic Outcomes of Graduated and Progressive Compression in Chronic Venous Disorders: A Meta-Analysis. [PDF]

Cureus
Hassan Awaji HH, Hamadelniel Alhadi IA, Badawi AHE, Manea FA, Altwiraqi RM, Alotaibi FM, Mohamed AM, Aloufi SN, Alsultan ZS, Alotaibi MA, Alhajraf A.   +10 more
europepmc   +1 more source

Tie2‐Dependent Mechanisms Influence Leptomeningeal Collateral Dynamics and Reperfusion Following Stroke

Advanced Science, EarlyView.
This work demonstrates that endothelial EphA4 limits Tie2 activation and curbs leptomeningeal collateral expansion after ischemic stroke. Pharmacological activation of Tie2 by an Ang‐1 mimetic or genetic loss of EphA4 stimulates collateral vessel growth, improves cerebral perfusion, and enhances neurological recovery.
Alexandra M. Kaloss, Caroline de Jager, Kennedie Lyles, Nathalie A. Groot, Jackie Zhu, Yu Lin, Michael Chen, Hehuang Xie, John B. Matson, Michelle H. Theus   +9 more
wiley   +1 more source

Active tuberculosis and venous thromboembolism: association according to international classification of diseases, ninth revision hospital discharge diagnosis codes.

Clinical Infectious Diseases, 2014
C. Dentan, O. Epaulard, D. Seynaeve, C. Genty, J. Bosson   +4 more
semanticscholar   +1 more source